Colorado Prevention Center

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

CollaboratorPhase 4Recruiting6,000 people3 Apr 2025clinicaltrials.gov

NCT06033950

Phase 3Recruiting2,600 people13 Sept 2023clinicaltrials.gov

NCT06024746

Phase 3Recruiting1,500 people6 Sept 2023clinicaltrials.gov

NCT06008197

Phase 3Recruiting5,200 people23 Aug 2023clinicaltrials.gov

NCT05284747

CollaboratorPhase 4Active, not recruiting6,019 people17 Mar 2022clinicaltrials.gov